WallStreetZenWallStreetZen

NASDAQ: ADMA
Adma Biologics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ADMA past revenue growth

How has ADMA's revenue growth performed historically?
Company
67.59%
Industry
149.3%
Market
17.29%
ADMA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADMA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADMA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADMA earnings and revenue history

Current Revenue
$258.2M
Current Earnings
-$28.2M
Current Profit Margin
-10.9%

ADMA Return on Equity

Current Company
-19.5%
Current Industry
-63.5%
Current Market
188%
ADMA's Return on Equity (-19.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADMA announces earnings.

ADMA Return on Assets

Current Company
-8.3%
Current Industry
2.9%
ADMA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADMA Return on Capital Employed

Current Company
-1.15%
Current Industry
19.5%
ADMA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADMA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADMA$258.22M$5.12M-$28.24M+72.34%N/A
EWTX$0.00-$98.43M-$100.16MN/AN/A
MORF$521.00k-$150.62M-$152.10M-31.11%N/A
KURA$0.00-$150.23M-$152.63MN/AN/A
GYRE$113.45M-$82.99M-$92.93M+164.06%N/A
View Top Biotech Stocks

ADMA earnings dates

Next earnings date
May 8, 2024

Adma Biologics Earnings & Revenue FAQ

What were ADMA's earnings last quarter?

On Invalid Date, Adma Biologics (NASDAQ: ADMA) reported Q4 2023 earnings per share (EPS) of -$0.08, up 33.33% year over year. Total Adma Biologics earnings for the quarter were -$17.64 million. In the same quarter last year, Adma Biologics's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Adma Biologics stock.

What was ADMA's earnings growth in the past year?

As of Q2 2024, Adma Biologics's earnings has grown year over year. Adma Biologics's earnings in the past year totalled -$28.24 million.

What is ADMA's earnings date?

Adma Biologics's earnings date is Invalid Date. Add ADMA to your watchlist to be reminded of ADMA's next earnings announcement.

What was ADMA's revenue last quarter?

On Invalid Date, Adma Biologics (NASDAQ: ADMA) reported Q4 2023 revenue of $73.90 million up 47.86% year over year. In the same quarter last year, Adma Biologics's revenue was $49.98 million.

What was ADMA's revenue growth in the past year?

As of Q2 2024, Adma Biologics's revenue has grown 67.59% year over year. This is 81.71 percentage points lower than the US Biotechnology industry revenue growth rate of 149.3%. Adma Biologics's revenue in the past year totalled $258.22 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.